# 1. Financial Performance ## A. Key Figures * **Consolidated Revenue:** **₹196.7 Cr** Q4 (+23.7%) · **₹683.2 Cr** FY26 (+15.9%) * **Consolidated EBITDA:** **₹34.3 Cr** Q4 (+38.9%) · **₹130.7 Cr** FY26 (+32.8%) * **Consolidated PAT:** **₹25.9 Cr** Q4 (+57.6%) · **₹96.8 Cr** FY26 (+39.7%) * **EBITDA Margin:** **17.4%** Cons. Q4 · **19.1%** Cons. FY26 · **24.3%** Stand-alone Q4 * **Cash Surplus:** **₹78.2 Cr** Net Debt-Free ## B. Revenue Growth * **Volume-Led Momentum:** Top-line expansion was primarily fueled by robust volume growth (contributing **60% to 65%** of the Q4 increase) rather than pricing actions. * **Growth Drivers:** Performance was further bolstered by a favorable product mix and tailwinds from rupee depreciation. * **Entity Performance:** Stand-alone operations delivered steady double-digit growth, while consolidated figures reflected stronger acceleration in the final quarter. ## C. Profitability and Margins * **Margin Expansion:** Significant bottom-line outperformance driven by sustained cost optimization and operating leverage from increased volumes. * **Manufacturing Efficiency:** New capacity at the Surat plant is projected to align with existing facility margins once fully operational. * **Geopolitical Monitoring:** Management continues to track external geopolitical impacts to protect current margin profiles. ## D. Balance Sheet Strength * **Liquidity Position:** Maintains a net debt-free status, providing significant financial flexibility for future scaling and capital deployment. * **Expected Inflows:** Anticipating a cash accrual in the current fiscal from a pending refund exceeding **$1.5 million**. --- # 2. Manufacturing & Capacity ## A. Key Figures * **Capacity Utilization:** **70% to 75%** FY26 average · **35%** FY27 target for new facility * **Revenue Potential:** **₹200 Cr to ₹250 Cr** peak top-line from Surat facility * **Volume Contribution:** **60% to 65%** of total company growth * **Modernization Capex:** **₹15 Cr to ₹20 Cr** allocated for FY27 ## B. Surat Facility Commencement * **Greenfield Operationalization:** Operations successfully commenced in late March 2026, with initial output contributing marginally to the previous fiscal year. * **Phased Scaling:** Phase 1 is currently operational with two lines; Phase 2 is slated for **Q3 FY27**, introducing a new line specifically for **pizza bases**. * **Utilization Roadmap:** Management expects the new site to reach full capacity by **Year 3**, with Phase 1 and Phase 2 projected to hit initial utilization rates of **35-40%** and **10-15%** respectively. ## C. Utilization & Expansion Strategy * **Volume-Led Growth:** Significant portion of expansion is driven by volume, supported by strategic debottlenecking and capacity additions in flatbread and snack lines at Nadiad and Nashik. * **Efficiency Investments:** Planned capital expenditure for FY27 focuses on further modernization and debottlenecking across existing manufacturing assets to sustain growth momentum. --- # 3. Brand & Product Performance ## A. Key Figures * **Ashoka Growth Guidance:** **30% to 35%** FY projection · **20% to 25%** Long-term trajectory * **Truly Indian Revenue:** **₹75 Cr - ₹80 Cr** Estimated FY total · **$4M - $4.5M** Current run rate * **Distribution Reach:** **3,000 stores** Truly Indian U.S. footprint * **Revenue Mix:** **70%** Owned Brands · **30%** B2B, Private Label & Distribution * **Product Portfolio:** **~600** Total SKUs (up from **440**) ## B. Ashoka Brand Momentum * **Flagship Dominance:** Ashoka remains the primary growth engine and financial bellwether, fueled by robust diaspora demand and expansion into staples, oils, and flour. * **Market Penetration:** Growth is underpinned by aggressive marketing and personnel investment across core hubs in North America, UK, Europe, and ANZ to mitigate regional concentration risks. * **Strategic Positioning:** Management views the brand's vegetarian/vegan profile as a tailwind for health-conscious consumers, noting zero negative impact from GLP-1/weight-loss drug trends. ## C. Truly Indian & Mainstream Expansion * **Mainstream Acceleration:** The brand is exceeding expectations in the U.S. retail channel, securing high-profile listings at **Costco, Safeway-Albertsons, and Whole Foods**. * **Award-Winning Innovation:** Recent accolades (NEXTY and Freezies Awards) for Naan products validate the brand's R&D and appeal to non-diaspora consumers. * **Global Costco Strategy:** Following success in the U.S. and Australia, the company is leveraging "rotations" to pitch the brand to Costco buyers in the **D. K. and Canada**. ## D. Distribution & B2B Scaling * **Non-Ashoka Growth Levers:** Achieving FY27 targets requires an estimated **INR 100 Cr** incremental contribution from the distribution segment. * **Portfolio Synergies:** Recent momentum in agency distribution is driven by adding complementary brands beyond the core tea portfolio and acquiring smaller regional brands. * **B2B Contribution:** The B2B and private label segment now accounts for approximately **20%** of total revenue, providing a diversified secondary income stream. --- # 4. Capital Allocation ## A. Key Figures * **Dividend:** **30%** final recommendation · **60%** total FY26 payout * **Historical Capex:** **₹124 Cr** total 2-year spend (Greenfield/Brownfield) * **Future Capex:** **₹20 Cr - ₹25 Cr** planned current fiscal * **PLI Incentive:** **₹16 Cr** FY26 accrual ## B. Dividend Distribution * **Shareholder Returns:** Board recommended a significant final payout, doubling the total dividend for the fiscal year relative to face value. ## C. Capex Review & Future Plans * **Infrastructure Scaling:** Multi-year investment cycle across Nadiad, Nashik, and Surat facilities culminated in the **March 2026** commercial launch of Surat Phase 1. * **Strategic Modernization:** Previous brownfield outlays of **₹40 Cr to ₹50 Cr** have been fully deployed for capacity expansion and factory upgrades. * **Near-Term Deployment:** Current year spending focuses on a new pizza base line and final Surat payments, with **₹10 Cr to ₹15 Cr** remaining for the Surat project completion. * **Surat Project Scope:** Total investment for both phases of the Surat facility is projected to slightly exceed **₹100 Cr** upon finalization. ## D. PLI Incentive Accruals * **Government Support:** Robust incentive recognition covers half of marketing expenditures; management expects similar accrual levels until the scheme concludes in **FY 2027**. --- # 5. Supply Chain & Logistics ## A. Key Figures * **Freight Cost Impact:** **3% to 4%** of total revenue · **₹6 Cr** estimated impact for March * **Warehouse Utilization (U.S.):** **>100%** Freezer capacity · **85%** Ambient storage ## B. Freight Cost Inflation * **Transitory Cost Spike:** Management views the late-quarter surge as an aberration driven by West Asia disruptions and vessel shortages, with costs already softening since mid-April. * **Stabilization Outlook:** While logistics expenses rose significantly in the short term, the situation is expected to normalize within **two months**, avoiding a sustained high-cost run rate. ## C. Warehouse Capacity Constraints * **Infrastructure Bottlenecks:** Critical freezer storage has exceeded maximum capacity, necessitating the use of expensive outside storage to manage high demand. * **Strategic Expansion:** Plans are underway to commission an **additional distribution center** in the **third quarter** to alleviate current utilization pressures. ## D. Shipping Route Disruptions * **Regional Market Impact:** The GCC market faced a near-total halt in shipments during March and April due to port closures and prohibitive freight rates. * **Cost Mitigation:** To maintain Middle East market presence, the company has implemented a **50-50 freight cost-sharing** agreement with local distributors. * **Operational Resilience:** Despite longer transit times, non-GCC export markets remain functional and continue to fulfill orders. --- # 6. Risks & Geopolitical Factors ## A. Key Figures * **GCC Revenue Contribution:** **<15%** of total revenues * **Regional Business Impact:** **80% to 85%** reduction in GCC market activity * **Revenue at Risk:** **₹30 Cr** estimated quarterly exposure ## B. Middle East Conflict & Logistics * **Shipping Paralysis:** Regional sales were negligible in March and April as shipping companies were unable to service the area due to active conflict. * **Temporary Halt vs. Long-term Outlook:** While shipments were specifically halted in March, management maintains a cautiously optimistic long-term trajectory through operational discipline. * **Resilience Amid Headwinds:** Overall growth was sustained despite significant geopolitical instability, supported by expanded distribution and previous listing gains. ## C. Regional Revenue Concentration * **Concentration Risk:** The conflict has severely impacted the GCC market, which represents a meaningful portion of the top line, though it remains a minority share of global operations. --- # 7. Guidance & Outlook ## A. Key Figures * **FY27 Revenue Guidance:** **₹925 Cr – ₹1,000 Cr** Base Case (+30%+) · **₹800 Cr – ₹850 Cr** Conservative Case (+12% – 15%) * **Ashoka Brand Target:** **~₹385 Cr** FY27 Contribution (+20% – 25%) * **Surat Facility Revenue:** **₹40 Cr – ₹50 Cr** Current FY · **₹200 Cr+** Full Capacity * **EBITDA Margin Guidance:** **High-teen** levels maintained through 2027 ## B. Revenue Target Scenarios * **Geopolitical Sensitivity:** Top-line targets are heavily contingent on the Middle East market, which represents **15% of total revenue**; normalization is required within **1 to 2 months** to hit the upper guidance band. * **Resilient Growth Floor:** Even in a "worst-case" scenario involving zero revenue contribution from the Middle East, management projects double-digit growth for the fiscal year. * **Capacity-Led Scaling:** Significant long-term upside is tied to the Surat facility, which is expected to provide a substantial multi-year revenue tailwind as it ramps to full capacity. ## C. Market Expansion Strategy * **Mainstream US Adoption:** Growth strategy pivots on the "ethnic to mainstream" shift in America, leveraging rising consumer demand for **vegan and healthy** product profiles.